Showing posts with label Vitreous Tamponades Market Research Report. Show all posts
Showing posts with label Vitreous Tamponades Market Research Report. Show all posts

Monday, 12 September 2016

Vitreous Tamponades Market Expected to Reach USD 77.5 Million Globally in 2020

The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V.
“Expansion of distribution networks and distributor subsidiaries is the strategy top companies in this market are adopting to augment sales,” points out a TMR analyst. For example, Alchimia Srl’s sales in the U.S. and Latin America are handled by Oftalmedia LLC, whereas its sales in other regions are handled by its Italy-based subsidiary BBS Srl.
The introduction of new products and new technologies is another key growth model that leading players in this market are exploring. Strategic mergers and acquisitions for the expansion of distributor base are on the growth plans of leading companies in the global vitreous tamponades market, adds TMR.
Declining Rate of Complications due to Diabetes in U.S. Challenges Market Growth
The major factor driving the global vitreous tamponades market is the increasing incidence of retinal detachment, macular pucker, and other ophthalmic conditions. Vitreous tamponades are used for the treatment of several vitreoretinal disorders such as retinal detachment, age-related macular degeneration, diabetic retinopathy, and vitreous hemorrhage. For instance, as per the International Diabetes Federation, almost 300 million individuals were affected with diabetes worldwide in 2010 and this number is expected to reach 438 million by 2030. A rising geriatric population that is susceptible to retinal disorders is also favoring the growth of the vitreous tamponades market.
“The commoditization of the vitreous tamponades market in Asia Pacific, Europe, and Rest of the World is challenging the growth of this market”, says a TMR analyst. Increasing demand for tamponades that are effective in the long-term and the price war that has spurred between local manufacturers and global vendors is adversely affecting industry revenue.
The decline in the incidence of diabetic retinopathy in North America is also slowing the growth of the global vitreous tamponades market. As per the American Diabetes Association, the complications arising due to diabetes have significantly reduced between 1990 and 2010 in the U.S. Moreover, the increasing number of awareness programs for routine eye examination carried out by governments and the World Health Organization has resulted in a considerable decline in the rate of proliferative diabetic retinopathy.
Gaseous Tamponades to Display Significant Growth Rate in Future
Liquid tamponades dominated the global vitreous tamponades market on the basis of product type in 2013, the segment held more than 49% of the overall market in the same year. The large market share of liquid tamponades is attributed to their extensive use in Europe and Asia for the treatment of retinal detachments with multiple breaks, proliferative diabetic retinopathy, giant tears, and proliferative vitreoretinopathy. Silicone oil liquid tamponades will register the fastest growth during the report’s forecast period. However, a high cost of silicone oil tamponades and their high chances of emulsification in the eye due to their low viscosity and surface tension are likely to limit the uptake of these tamponades. Perfluorocarbons liquid tamponades will display a constant growth rate as they are largely used for reattaching giant retinal tears.
On the other hand, gaseous tamponades will display the highest growth rate due to their low risk of emulsification, ease of use, and reduced cost.
The global vitreous tamponades market is expected to reach a valuation of US$77.5 mn by 2020.
The information presented in this review is based on a Transparency Market Research study, titled, “Vitreous Tamponades Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”

Sunday, 17 January 2016

Vitreous Tamponades Market - Global Industry Analysis, Trends and Forecast 2014 - 2020

 Vitreous tamponades are widely used in vitrectomy procedures worldwide as a vital element in healing process of vitreoretinal disorders. Vitreous tamponades have evolved only to a small extent since the past few decades in ophthalmological procedures. Instead vitrectomy procedures have evolved to a great extent with the inclusion of various instrumental advancements. These instrumental advancements have further increased the effectiveness of vitreous tamponades in terms of their applicability and healing rate. Vitreous tamponades are generally classified into gaseous tamponades and liquid tamponades. Gaseous tamponades are often used in dilution with sterile air and are highly effective for treating small retinal tears. Gaseous tamponades are also highly effective in terms of low toxicity and ease of application. In addition, gaseous tamponades have lower emulsification risk and require fewer revisits. Liquid tamponades on the other hand are effective for larger tears. They however have lower risk of expansion due to pressure changes in the atmosphere, thereby rendering them safe for air travel. Overall vitreous tamponades show great potential for treating majority of the severe vitreoretinal disorders that require surgical intervention. Transparency Market Research, a leading U.S. based market research firm, analyzes the global market for vitreous tamponades and predicts a compounded annual growth rate of 2.5% for the period 2014 to 2020.
Browse the full Vitreous Tamponades Market (Tamponades Types: Gaseous Tamponades and Liquid Tamponades [Silicone Oil, Perfluorocarbons]) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/vitreous-tamponades-market.html
The global vitreous tamponades industry is broadly categorized on the basis of product types and geographies. The vitreous tamponades product category is further segmented into gaseous tamponades and liquid tamponades. Among these sub segments, the market for liquid tamponades exhibits the largest share in 2013, whereas gaseous tamponades show the highest growth rate during the forecast period 2014 – 2020. The high prevalence of larger retina tear, and ophthalmologist preference for liquid tamponades in major economies in the world have lead to the growth of liquid tamponade segment in the world. The gaseous tamponade segment is however expected to lead the market in terms of growth rate. Gaseous tamponade is the most preferred segment in the North American region which is supported by low incidence of diabetic retinopathy in developed nations.
Geographically, in 2013 the global vitreous tamponades market is lead by the North America, followed by Europe. The dominance of this region was majorly due to rising diabetic population, increasing surgeons coupled with high cost of vitreoretinal surgery equipment. The Asia-Pacific market is forecast to grow at the highest growth rate during the forecast period of 2014 to 2020. The contributing factors for Asia Pacific growth include: large geriatric population, low penetration of healthcare facilities, favorable & supportive government policies, low technology cost & other overheads, adoption of novel technologies, growing awareness of basic healthcare, and the fact that Asia is the largest and fastest growing population in the world. In addition, presence of large number of tamponade manufacturers offering products readily and at an affordable cost further propels the growth of vitreous tamponades in Asia-Pacific.
The leading players in this market include: Alcon, Inc., Fluoron GmbH and Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), to name a few. Among these Alcon, Inc. was found to have the largest global presence, offering a wide range of vitreous tamponade products globally. The other companies include: Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma Pharma AG, and AL.CHI.MI.A Srl, to name a few.

Thursday, 10 December 2015

Vitreous Tamponades Market - Global Industry Analysis, Trends and Forecast 2014 - 2020

The vitreous tamponades market is said to be transforming steadily from liquid tamponades to gaseous tamponades, worldwide. Vitreous tamponades are elements used in vitrectomy procedures performed on the human eye that aid in reattaching or healing the retina and provide a substitute to a clouded vitreous humor. Vitreous substitutes are used in the treatment of vitreoretinal disorders and are biocompatible, transparent, and elastic surgical adjuncts. They are used as an intra-operative or as a postoperative mechanism to cure vitreoretinal disorders. In 1970’s, modern vitrectomy techniques were launched and since then the usage of vitreous substitutes has been extensive in reattachment procedures of the retina. Nowadays, the most regularly used vitreous substitutes are silicone oil, perfluorocarbon liquids, and intraocular gases.
The global vitreous tamponades market was valued at US$64.5 million in 2013 and, expanding at a CAGR of 2.5% from 2014 to 2020, is expected to reach US$77.5 million by 2020. Substantial growth of the vitreous tamponades market is seen due to the rising prevalence of diabetic retinopathy, macular pucker, retinal detachments, and other retinal disorders. Globally, an increase in elderly population is also seen as one of the dominant factors likely to augment the demand for vitreous tamponades, as the geriatric population is more vulnerable to retinal breaks and demand immediate care.
Gaseous Tamponades Dominate North America, Liquid Tamponades Rule in Asia and Europe
Gaseous and liquid tamponades amount to a comprehensive commercial market for vitreous tamponades. In 2013, in terms of revenue, liquid tamponades emerged as the leader, accounting for more than 49% of the global market. This preeminence was achieved due to the extensive preference for liquid tamponades over gaseous tamponades in the Asian and European markets to treat retinal disengagement with numerous breaks (superior and inferior), proliferative, giant tears, diabetic retinopathy, and proliferative vitreoretinopathy.
Based on geographical segmentation, the global vitreous tamponades market has been segmented primarily into four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). In terms of revenue, North America was the biggest regional market globally in 2013. Due to the on-label use of gaseous tamponades and the comfort of use it provides to physicians and patients, gaseous tamponades accounted for the largest share of the market in North America.
Silicone Oil: The Fastest Growing Segment of the Vitreous Tamponades Market
The liquid tamponades market has been segregated into silicone oil and perfluorocarbon liquid. Among these two, silicone oil has been singled out to be the segment expected to grow rapidly from 2014 to 2020. Silicone oils are commonly called permanent tamponades and are detached from the site in the timeframe of four to six weeks after the surgery. However, because of their low glutinousness and surface tensity, traditional silicone oils tend to become foggy and develop tiny balloons inside the eye, which can lead to ailments such as glaucoma and inflammation.
Such detrimental possibilities have led to the development of silicone oil types with higher glutinousness, in order to lessen the chances of it becoming foggy over time. However, soaring costs of silicone oils compared to gases and the need for a second operation for the elimination of silicone oil several months after the insertion surgery are the key factors likely to hamper the growth of silicone oils in the near future. Perfluorocarbons, on the contrary, are expected to achieve a consistent growth rate, as these tamponades are mainly used for the reattachment of colossal retinal tears.
Key players in vitreous tamponades include both medium and small-sized manufacturers such as Alcon, Inc., Valeant Pharmaceuticals International, Inc., Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, Croma Pharma AG, and AL.CHI.MI.A Srl.
Browse Full Global Vitreous Tamponades Market Report With Complete TOC @ http://www.transparencymarketresearch.com/vitreous-tamponades-market.html
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453